Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × fludarabine phosphate × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Myelodysplastic Syndromes 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Non-Hodgkin 9 Multiple Myeloma 8 Melanoma 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia, Biphenotypic, Acute 7 Hematologic Neoplasms 7 Lymphoma, Mantle-Cell 6 Lymphoma, Follicular 6 Lymphoma 6 Leukemia 6 Hodgkin Disease 6 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 4 Lymphoma, B-Cell 4 Hematologic Diseases 4 Anemia, Refractory, with Excess of Blasts 4 Skin Neoplasms 3 Lymphoproliferative Disorders 3 Leukemia, Lymphoid 3 Leukemia, B-Cell 3 Uveal Melanoma 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Primary Myelofibrosis 2

Interventions

Dexamethasone 15 Cyclophosphamide 12 pembrolizumab 11 Rituximab 11 venetoclax 10 pomalidomide 10 fludarabine 9 Lenalidomide 8 Calcium Dobesilate 7 glofitamab 6 Gemcitabine 6 Cytarabine 6 carfilzomib 5 Temozolomide 5 Nivolumab 5 Etoposide 5 Bevacizumab 5 selinexor 4 ruxolitinib 4 obinutuzumab 4 daratumumab 4 Doxorubicin 4 Carboplatin 4 Capecitabine 4 Bortezomib 4 Azacitidine 4 zanubrutinib 3 tisagenlecleucel 3 elotuzumab 3 blinatumomab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡